Sign up to receive Dana-Farber Spotlight, our email newsletter.View the current issueSubscribe nowUnsubscribe from mailings
Ellen BerlinDirector of Media Relations617email@example.com
Molly McHaleAssociate Director of Media Relations617firstname.lastname@example.org
Dr. Pasi Janne comments on the failure of a new drug as an initial treatment for patients with lung cancer.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: